Analytical performance specifications based on biological variation data - considerations, strengths and limitations

被引:5
作者
Sandberg, Sverre [1 ,2 ,3 ]
Coskun, Abdurrahman [4 ]
Carobene, Anna [5 ]
Fernandez-Calle, Pilar [6 ]
Diaz-Garzon, Jorge [6 ]
Bartlett, William A. [7 ]
Jonker, Niels [8 ]
Galior, Kornelia [9 ]
Gonzales-Lao, Elisabet [10 ]
Moreno-Parro, Isabel [6 ]
Sufrate-Vergara, Berta [6 ]
Webster, Craig [11 ]
Aarsand, Aasne K. [1 ,2 ]
机构
[1] Haraldsplass Deaconess Hosp, Norwegian Org Qual Improvement Lab Examinat Noklu, Bergen, Norway
[2] Haukeland Hosp, Norwegian Porphyria Ctr, Dept Med Biochem & Pharmacol, Bergen, Norway
[3] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway
[4] Acibadem Mehmet Ali Aydinlar Univ, Sch Med, Dept Med Biochem Atasehir, Istanbul, Turkiye
[5] IRCCS San Raffaele Sci Inst, Lab Med, Milan, Italy
[6] La Paz Univ Hosp, Lab Med Dept, Madrid, Spain
[7] Univ Dundee, Sch Engn & Sci, Biomed Engn, Dundee, Scotland
[8] Wilhelmina Ziekenhuis Assen, Certe, Assen, Netherlands
[9] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA USA
[10] Consorci Sanit Terrassa Univ Hosp, Qual & Patient Safety Dept, Barcelona, Spain
[11] Univ Hosp Birmingham, Dept Biochem Immunol & Toxicol, Birmingham, W Midlands, England
关键词
analytical performance specifications; biological variation; precision; bias; total error; measurement uncertainty; QUALITY SPECIFICATIONS; CLINICAL-CHEMISTRY; ANALYTICAL GOALS; UNCERTAINTY; STANDARDS; PRECISION; ERROR;
D O I
10.1515/cclm-2024-0108
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Analytical performance specifications (APS) are typically established through one of three models: (i) outcome studies, (ii) biological variation (BV), or (iii) state-of-the-art. Presently, The APS can, for most measurands that have a stable concentration, be based on BV. BV based APS, defined for imprecision, bias, total allowable error and allowable measurement uncertainty, are applied to many different processes in the laboratory. When calculating APS, it is important to consider the different APS formulae, for what setting they are to be applied and if they are suitable for the intended purpose. In this opinion paper, we elucidate the background, limitations, strengths, and potential intended applications of the different BV based APS formulas. When using BV data to set APS, it is important to consider that all formulae are contingent on accurate and relevant BV estimates. During the last decade, efficient procedures have been established to obtain reliable BV estimates that are presented in the EFLM biological variation database. The database publishes detailed BV data for numerous measurands, global BV estimates derived from meta-analysis of quality-assured studies of similar study design and automatic calculation of BV based APS.
引用
收藏
页码:1483 / 1489
页数:7
相关论文
共 26 条
  • [1] The Biological Variation Data Critical Appraisal Checklist: A Standard for Evaluating Studies on Biological Variation
    Aarsand, Aasne K.
    Roraas, Thomas
    Fernandez-Calle, Pilar
    Ricos, Carmen
    Diaz-Garzon, Jorge
    Jonker, Niels
    Perich, Carmen
    Gonzalez-Lao, Elisabet
    Carobene, Anna
    Minchinela, Joana
    Coskun, Abdurrahman
    Simon, Margarita
    Alvarez, Virtudes
    Bartlett, William A.
    Fernandez-Fernandez, Pilar
    Boned, Beatriz
    Braga, Federica
    Corte, Zoraida
    Aslan, Berna
    Sandberg, Sverre
    [J]. CLINICAL CHEMISTRY, 2018, 64 (03) : 501 - 514
  • [2] Aarsand AK., The EFLM biological variation database
  • [3] BIPM IEC IFCC, 1993, Guide to the Expression of Uncertainty in Measure-ment
  • [4] Criteria for assigning laboratory measurands to models for analytical performance specifications defined in the 1st EFLM Strategic Conference
    Ceriotti, Ferruccio
    Fernandez-Calle, Pilar
    Klee, George G.
    Nordin, Gunnar
    Sandberg, Sverre
    Streichert, Thomas
    Vives-Corrons, Joan-Lluis
    Panteghini, Mauro
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2017, 55 (02) : 189 - 194
  • [5] Measurement uncertainty for practical use
    Coskun, Abdurrahman
    Theodorsson, Elvar
    Oosterhuis, Wytze P.
    Sandberg, Sverre
    [J]. CLINICA CHIMICA ACTA, 2022, 531 : 352 - 360
  • [6] Eisenhart C., 1963, J RES NAT BUR STAND, V67C, P161
  • [7] Elevitch F., 1977, P 1976 ASPEN C ANALY
  • [8] DESIRABLE PERFORMANCE STANDARDS FOR CLINICAL-CHEMISTRY TESTS
    FRASER, CG
    [J]. ADVANCES IN CLINICAL CHEMISTRY, 1983, 23 : 299 - 339
  • [9] Proposals for setting generally applicable quality goals solely based on biology
    Fraser, CG
    Petersen, PH
    Libeer, JC
    Ricos, C
    [J]. ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 : 8 - 12
  • [10] FRASER CG, 1993, CLIN CHEM, V39, P1447